Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine' by Mathian et al

Ann Rheum Dis. 2022 Nov;81(11):e216. doi: 10.1136/annrheumdis-2020-218778. Epub 2020 Aug 28.

¹ Department of Anesthesiology and Critical Care, Universitätsklinikum Würzburg, Würzburg, Germany Notz_Q@ukw.de.
² Department of Anesthesiology and Critical Care, Universitätsklinikum Würzburg, Würzburg, Germany.
³ Department of Internal Medicine I, Critical Care, Universitätsklinikum Würzburg, Würzburg, Germany.
⁴ Department of Internal Medicine II, Rheumatology, Universitätsklinikum Würzburg, Würzburg, Germany.

No abstract available

Keywords: B-lymphocytes; inflammation; rituximab.

Publication types